PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Tumour immune cells could aid cancer therapies

A pioneering technique designed to spot differences between immune cells in tumours could speed the development of cancer treatments, research suggests. Scientists sa...
Continue Reading →
news

New genetic culprit found for early progressive hair loss

One gene may drive the mechanisms behind a rare form of hair loss. Many people face hair loss, but only a fe...
Continue Reading →
news

Abeona inks deal with Regenxbio for gene therapy vector supply

Abeona Therapeutics has inked a deal with Regenxbio to secure supply of AAV9 vector for gene therapies targeting four rare lysosomal disorders, including Sanfilipp...
Continue Reading →
news

Solving a century-old neuroscience puzzle may lead to epilepsy therapy

Virginia Tech scientists suggest their new research on perineuronal nets could lead to new approach against epilepsy.[...
Continue Reading →
news

Japan conducts world’s first iPS cell transplant for Parkinson’s

The team intends to develop a mass production system that enables the delivery of nerve cells derived from iPS cells all over the world. A research team from Ky...
Continue Reading →
news

AMAL Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round

Second closing of Series B raises €21.2 million (CHF 24.2 million) Funding to support clinical development of lead vaccine and extension of KISIMA® technology pl...
Continue Reading →
news

RetiPharma Secures Funding to Develop Treatments of Degenerative Eye Disorders

Advancing novel mode-of-action drug and building a unique translational in vivo platform Copenhagen, Denmark, November 12, 2018 / B3C newswire / -- RetiPharma, focus...
Continue Reading →
news

Icosabutate Latest Data Shows Direct and Potent Anti-Fibrotic Effect in Both Differentiated Rodent NASH Models and Human Stellate Cells

Results to be presented at the AASLD congress 2018, 9-13 November In a biopsy-confirmed fibrotic ob/ob NASH mouse model, icosabutate reduced hepatic fibrosis in as...
Continue Reading →
news

ProBioGen Announces Successful Bispecific GlymaxX® Development Project for Zymeworks

Berlin, Germany, November 06, 2018 / B3C newswire / -- ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins ...
Continue Reading →
news

NUS scientists find novel method to cultivate human skin cells for grafting

This new and safer system can potentially replace conventional animal-cell based culture method that has been used for over four decades and is currently restricted t...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC